FDA Announces Joint Meeting of Advisory Committees to Discuss Peripheral and Central Nervous System Drugs, Psychopharmacologic Drugs

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Psychopharmacologic Drugs Advisory Committee to discuss various topics related to these drug categories, as announced in the Federal Register on October 3, 2023.